Perinatal AD.
Primary objectives: To determine:
the prevalence of maternal AD at 6–8 weeks postpartum, and
if additional screening beyond the EPDS is required in order to ensure adequate detection of AD among postpartum women.
Secondary objectives: To determine:
the level of comorbidity of mood and AD at 6–8 weeks postpartum,
the temporal sequencing of AD and mood disorders during pregnancy and at 6–8 weeks postpartum, and
the course of anxiety symptoms from pregnancy to 6–8 weeks postpartum.